Tacrolimus (FK506) causes disease aggravation in models for inherited peripheral myelinopathies

Our study shows that FK506 may not be suitable for the treatment of the human nerve disorders. Furthermore, when used as an immunosuppressant, the drug may generate detrimental neurological side effects in patients with an additional hereditary neuropathy.